Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286295652> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4286295652 endingPage "4007" @default.
- W4286295652 startingPage "4007" @default.
- W4286295652 abstract "4007 Background: The benefit of adapted physical activity (APA) on health-related quality of life (HRQoL) in Pts with advanced pancreatic ductal adenocarcinoma (aPDAC) treated by chemotherapy (CTx) has never been prospectively assessed. Methods: Pts with aPDAC and ECOG performance status (PS) 0–2 were randomized 1:1 to receive usual care (UC) including first-line CTx at the investigator’s choice (standard arm), or UC plus a home-based 16-week APA program (APA arm). The APA program consisted of personalized aerobic and resistance exercises, with a weekly remote supervision by an APA professional trainer, and unsupervised sessions with a family member or friend (APA partner). The primary objective was the effect on HRQoL at week 16 (W16) measured by 3 dimensions of the EORTC QLQ-C30, global health status (GHS), physical functioning (PF), and fatigue (FA), with a one-sided type I error of 0.016 for each dimension. The primary HRQoL analysis was performed in Pts with available baseline and W16 scores for the 3 targeted dimensions (mITT1). Secondary analyses of HRQoL changes by the mixed model for repeated measures (MMRM) and time until definitive deterioration (TUDD) methods included Pts with baseline and ≥1 follow-up score (mITT2). Differences > 5 points in scores were considered clinically significant. Results: A total of 313 Pts (median age: 64 years; men: 55%, ECOG PS 0-1: 93%; metastatic: 77%; FOLFIRINOX: 78%, gemcitabine-based: 13%) were included from 11/2014 to 10/2020 (standard arm: n = 157, APA arm: n = 156). In the mITT1 population (n = 172), mean differences in HRQoL at W16 adjusted from baseline were -0.98 (SD 23.87; p = 0.39), -2.08 (SD 21.34; p = 0.26), and 4.16 (SD 29.18; p = 0.18) for GHS, PF, and FA, respectively. In the mITT2 population (n = 259), APA was associated with significant improvements in 5 (GHS, PF, cognitive functioning [CF], social functioning [SF], appetite loss) and 8 (GHS, CF, emotional functioning [EF], SF, insomnia, constipation, pain, financial difficulties) dimensions of HRQoL by MMRM and TUDD, respectively (Table). Secondary endpoints, including overall survival, progression-free survival, and chemotherapy toxicity will be presented. Conclusions: APA in combination with usual care improved several dimensions of HRQoL in Pts with aPDAC receiving first-line CTx. Clinical trial information: NCT02184663. [Table: see text]" @default.
- W4286295652 created "2022-07-21" @default.
- W4286295652 creator A5008077511 @default.
- W4286295652 creator A5012447228 @default.
- W4286295652 creator A5013525685 @default.
- W4286295652 creator A5017534234 @default.
- W4286295652 creator A5020893157 @default.
- W4286295652 creator A5020997210 @default.
- W4286295652 creator A5032401895 @default.
- W4286295652 creator A5050778016 @default.
- W4286295652 creator A5054069734 @default.
- W4286295652 creator A5065121477 @default.
- W4286295652 creator A5067816598 @default.
- W4286295652 creator A5074346281 @default.
- W4286295652 creator A5075053811 @default.
- W4286295652 creator A5077000250 @default.
- W4286295652 creator A5080894198 @default.
- W4286295652 creator A5084470537 @default.
- W4286295652 creator A5086294065 @default.
- W4286295652 creator A5086966836 @default.
- W4286295652 date "2022-06-01" @default.
- W4286295652 modified "2023-10-16" @default.
- W4286295652 title "Adapted physical activity in patients (Pts) with advanced pancreatic cancer (APACaP): Results from a prospective national randomized GERCOR trial." @default.
- W4286295652 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.4007" @default.
- W4286295652 hasPublicationYear "2022" @default.
- W4286295652 type Work @default.
- W4286295652 citedByCount "7" @default.
- W4286295652 countsByYear W42862956522022 @default.
- W4286295652 countsByYear W42862956522023 @default.
- W4286295652 crossrefType "journal-article" @default.
- W4286295652 hasAuthorship W4286295652A5008077511 @default.
- W4286295652 hasAuthorship W4286295652A5012447228 @default.
- W4286295652 hasAuthorship W4286295652A5013525685 @default.
- W4286295652 hasAuthorship W4286295652A5017534234 @default.
- W4286295652 hasAuthorship W4286295652A5020893157 @default.
- W4286295652 hasAuthorship W4286295652A5020997210 @default.
- W4286295652 hasAuthorship W4286295652A5032401895 @default.
- W4286295652 hasAuthorship W4286295652A5050778016 @default.
- W4286295652 hasAuthorship W4286295652A5054069734 @default.
- W4286295652 hasAuthorship W4286295652A5065121477 @default.
- W4286295652 hasAuthorship W4286295652A5067816598 @default.
- W4286295652 hasAuthorship W4286295652A5074346281 @default.
- W4286295652 hasAuthorship W4286295652A5075053811 @default.
- W4286295652 hasAuthorship W4286295652A5077000250 @default.
- W4286295652 hasAuthorship W4286295652A5080894198 @default.
- W4286295652 hasAuthorship W4286295652A5084470537 @default.
- W4286295652 hasAuthorship W4286295652A5086294065 @default.
- W4286295652 hasAuthorship W4286295652A5086966836 @default.
- W4286295652 hasConcept C121608353 @default.
- W4286295652 hasConcept C126322002 @default.
- W4286295652 hasConcept C159110408 @default.
- W4286295652 hasConcept C168563851 @default.
- W4286295652 hasConcept C1862650 @default.
- W4286295652 hasConcept C2779951463 @default.
- W4286295652 hasConcept C2780210213 @default.
- W4286295652 hasConcept C2780258809 @default.
- W4286295652 hasConcept C2908647359 @default.
- W4286295652 hasConcept C71924100 @default.
- W4286295652 hasConcept C99454951 @default.
- W4286295652 hasConceptScore W4286295652C121608353 @default.
- W4286295652 hasConceptScore W4286295652C126322002 @default.
- W4286295652 hasConceptScore W4286295652C159110408 @default.
- W4286295652 hasConceptScore W4286295652C168563851 @default.
- W4286295652 hasConceptScore W4286295652C1862650 @default.
- W4286295652 hasConceptScore W4286295652C2779951463 @default.
- W4286295652 hasConceptScore W4286295652C2780210213 @default.
- W4286295652 hasConceptScore W4286295652C2780258809 @default.
- W4286295652 hasConceptScore W4286295652C2908647359 @default.
- W4286295652 hasConceptScore W4286295652C71924100 @default.
- W4286295652 hasConceptScore W4286295652C99454951 @default.
- W4286295652 hasIssue "16_suppl" @default.
- W4286295652 hasLocation W42862956521 @default.
- W4286295652 hasOpenAccess W4286295652 @default.
- W4286295652 hasPrimaryLocation W42862956521 @default.
- W4286295652 hasRelatedWork W2073827132 @default.
- W4286295652 hasRelatedWork W2094153719 @default.
- W4286295652 hasRelatedWork W2126322332 @default.
- W4286295652 hasRelatedWork W2319496893 @default.
- W4286295652 hasRelatedWork W2596055884 @default.
- W4286295652 hasRelatedWork W2885862304 @default.
- W4286295652 hasRelatedWork W3031244932 @default.
- W4286295652 hasRelatedWork W3031675857 @default.
- W4286295652 hasRelatedWork W4205828341 @default.
- W4286295652 hasRelatedWork W4242945331 @default.
- W4286295652 hasVolume "40" @default.
- W4286295652 isParatext "false" @default.
- W4286295652 isRetracted "false" @default.
- W4286295652 workType "article" @default.